The age-related increase in N-methyl-2-pyridone-5-carboxamide (NAD catabolite) in human plasma
- PMID: 15663182
- DOI: 10.1023/b:mcbi.0000049359.66669.29
The age-related increase in N-methyl-2-pyridone-5-carboxamide (NAD catabolite) in human plasma
Abstract
N-Methyl-2-pyridone-5-carboxamide (2PY) is a major catabolite of NAD, which is excreted in the urine. Assay of plasma concentration and urine exrection of 2PY is of interest for monitoring niacin nutritional state and NAD catabolism. Aging has major impact on number of metabolic processes, but its effect on plasma and tissue 2PY concentration has not been studied so far. The present study was undertaken to investigate the effect of aging on human plasma 2PY concentration. Blood samples were collected from 78 (56 females and 22 males) healthy subjects at different age ranging from 5 to 90 years. Plasma ultrafiltrates were analyzed with liquid chromatography/mass spectrometry (LC/MS) for 2PY concentration. 2PY concentration was also evaluated in plasma and liver of young (2 month) and old (24 month) rats. The mean plasma 2PY concentration in young (5-16 years old) healthy subjects was 0.39 +/- 0.22 micromol/l while in old healthy subjects (50-90 years old) it was approximately 2.6-fold higher. No gender differences was found in plasma 2PY concentration. Univariate regression analysis displayed positive correlation between age and human plasma 2PY concentration (r = 0.57, p < 0.01) and between age and 2PY/creatinine ratio (r = 0.4, p < 0.01). Multivariate regression analysis indicates that both age and plasma creatinine concentrations were independently correlated with the increase in plasma 2PY concentration. Daily 2PY excretion with urine corrected for weight was approximately 30% lower in old subjects than in young humans. 2PY concentrations in liver and plasma of 2-month-old rats were lower than in 24-month-old rats. In conclusion, our results demonstrated that human plasma 2PY concentration increases with age. This could be a consequence of both decreased renal excretion and increased production in the the liver or other organs. Our results indicate that age should be taken into consideration in the interpretation of plasma 2PY concentration.
Similar articles
-
Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure.Mol Cell Biochem. 2002 Feb;231(1-2):83-8. doi: 10.1023/a:1014445329756. Mol Cell Biochem. 2002. PMID: 11952169
-
Urinary Excretion of N1-Methylnicotinamide and N1-Methyl-2-Pyridone-5-Carboxamide and Mortality in Kidney Transplant Recipients.Nutrients. 2020 Jul 10;12(7):2059. doi: 10.3390/nu12072059. Nutrients. 2020. PMID: 32664445 Free PMC article.
-
N-methyl-2-pyridone-5-carboxamide: a novel uremic toxin?Kidney Int Suppl. 2003 May;(84):S19-21. doi: 10.1046/j.1523-1755.63.s84.36.x. Kidney Int Suppl. 2003. PMID: 12694300 Review.
-
Urinary Excretion of N1-methyl-2-pyridone-5-carboxamide and N1-methylnicotinamide in Renal Transplant Recipients and Donors.J Clin Med. 2020 Feb 6;9(2):437. doi: 10.3390/jcm9020437. J Clin Med. 2020. PMID: 32041099 Free PMC article.
-
N-methyl-2-pyridone-5-carboxamide (2PY)-Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin.Toxins (Basel). 2016 Nov 15;8(11):339. doi: 10.3390/toxins8110339. Toxins (Basel). 2016. PMID: 27854278 Free PMC article. Review.
Cited by
-
Dysregulated nicotinamide adenine dinucleotide metabolome in patients hospitalized with COVID-19.Aging Cell. 2024 Dec;23(12):e14326. doi: 10.1111/acel.14326. Epub 2024 Oct 1. Aging Cell. 2024. PMID: 39354697 Free PMC article.
-
COVID-19: Are We Facing Secondary Pellagra Which Cannot Simply Be Cured by Vitamin B3?Int J Mol Sci. 2022 Apr 13;23(8):4309. doi: 10.3390/ijms23084309. Int J Mol Sci. 2022. PMID: 35457123 Free PMC article. Review.
-
4-Pyridone-3-carboxamide-1-β-D-ribonucleoside triphosphate (4PyTP), a novel NAD metabolite accumulating in erythrocytes of uremic children: a biomarker for a toxic NAD analogue in other tissues?Toxins (Basel). 2011 Jun;3(6):520-37. doi: 10.3390/toxins3060520. Epub 2011 Jun 7. Toxins (Basel). 2011. PMID: 22069723 Free PMC article. Clinical Trial.
-
Roles of NAD+ in Acute and Chronic Kidney Diseases.Int J Mol Sci. 2022 Dec 21;24(1):137. doi: 10.3390/ijms24010137. Int J Mol Sci. 2022. PMID: 36613582 Free PMC article. Review.
-
Time-restricted feeding ameliorates non-alcoholic fatty liver disease through modulating hepatic nicotinamide metabolism via gut microbiota remodeling.Gut Microbes. 2024 Jan-Dec;16(1):2390164. doi: 10.1080/19490976.2024.2390164. Epub 2024 Aug 18. Gut Microbes. 2024. PMID: 39154362 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical